Key details
Sponsor
Chipscreen Biosciences, Ltd.
Enrollment target
~454 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated October 2024